Daiwa Securities Group Inc. Purchases 1,131 Shares of Axon Enterprise, Inc $AXON

Daiwa Securities Group Inc. increased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 4.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,234 shares of the biotechnology company’s stock after purchasing an additional 1,131 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Axon Enterprise were worth $14,332,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. NEOS Investment Management LLC increased its position in Axon Enterprise by 82.7% during the 3rd quarter. NEOS Investment Management LLC now owns 25,369 shares of the biotechnology company’s stock worth $18,206,000 after purchasing an additional 11,482 shares in the last quarter. Legal & General Group Plc increased its position in Axon Enterprise by 1.3% during the 4th quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock worth $242,241,000 after purchasing an additional 5,419 shares in the last quarter. Vanguard Group Inc. increased its position in Axon Enterprise by 4.2% during the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after purchasing an additional 376,904 shares in the last quarter. Eurizon Capital SGR S.p.A. acquired a new position in Axon Enterprise in the 4th quarter valued at approximately $13,116,000. Finally, Wealth Enhancement Advisory Services LLC raised its stake in shares of Axon Enterprise by 93.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock valued at $13,270,000 after acquiring an additional 11,262 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently weighed in on AXON. Piper Sandler reduced their price objective on shares of Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating on the stock in a research note on Thursday, May 7th. Zacks Research raised shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. Royal Bank Of Canada reduced their price objective on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 25th. Craig Hallum reissued a “buy” rating and issued a $820.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 25th. Finally, Citigroup reissued a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $712.75.

Check Out Our Latest Stock Analysis on Axon Enterprise

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $486.12 on Friday. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91. The firm has a fifty day simple moving average of $408.04 and a 200 day simple moving average of $491.92. The company has a market capitalization of $39.18 billion, a PE ratio of 195.23, a P/E/G ratio of 8.84 and a beta of 1.45. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business’s quarterly revenue was up 33.7% on a year-over-year basis. During the same period last year, the company posted $1.47 earnings per share. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 1.82 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In related news, Director Erika Nardini sold 198 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total transaction of $100,302.84. Following the transaction, the director directly owned 1,946 shares of the company’s stock, valued at $985,804.68. This trade represents a 9.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $478.97, for a total transaction of $270,139.08. Following the transaction, the director directly owned 3,632 shares in the company, valued at $1,739,619.04. The trade was a 13.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,548 shares of company stock valued at $1,542,775 over the last three months. Corporate insiders own 4.20% of the company’s stock.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.